ABL Attends ImVacs Immunotherapies and Vaccine Summit

ABL Attends ImVacs Immunotherapies and Vaccine Summit

  • Aug 11-13, 2014
  • Boston

ABL attended the 9th Annual Immunotherapeutics and Vaccine Summit (ImVacs) in Boston from August 11-13.

ABL representatives met with innovators and collaborators to discuss novel vaccines, immunotherapies for cancer, and T cell therapy. For more information regarding ABL’s capabilities in preclinical research, clinical immunomonitoring and assay development, and production of vaccines and biotherapeutics, contact us.